EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pharmacology of Adenosine Receptors: Recent Advancements

Fabrizio Vincenzi iD, Silvia Pasquini iD, Chiara Contri iD, Martina Cappello, Manuela Nigro, Alessia Travagli, Stefania Merighi iD, Stefania Gessi, Pier Andrea Borea, Katia Varani iD

Biomolecules · 14.09.2023 · 13 (9) · 1387

DOI: 10.3390/biom13091387 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 14.09.2023. Verfasst von Fabrizio Vincenzi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy. Hauptthemen laut MEDLINE: Receptors, Purinergic P1, Purinergic P1 Receptor Antagonists. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 212 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of University and Research (MUR), Ministry of University and Research (MUR) National Recovery and Resilience Plan (NRRP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adenosine receptors (ARs) are widely acknowledged pharmacological targets yet are still underutilized in clinical practice. Their ubiquitous distribution in almost all cells and tissues of the body makes them, on the one hand, excellent candidates for numerous diseases, and on the other hand, intrinsically challenging to exploit selectively and in a site-specific manner. This review endeavors to comprehensively depict the substantial advancements witnessed in recent years concerning the development of drugs that modulate ARs. Through preclinical and clinical research, it has become evident that the modulation of ARs holds promise for the treatment of numerous diseases, including central nervous system disorders, cardiovascular and metabolic conditions, inflammatory and autoimmune diseases, and cancer. The latest studies discussed herein shed light on novel mechanisms through which ARs exert control over pathophysiological states. They also introduce new ligands and innovative strategies for receptor activation, presenting compelling evidence of efficacy along with the implicated signaling pathways. Collectively, these emerging insights underscore a promising trajectory toward harnessing the therapeutic potential of these multifaceted targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Purinergic P1Purinergic P1 Receptor AntagonistsHumansAnimalsSignal TransductionNeoplasmsLigandsAutoimmune DiseasesCardiovascular Diseases

Stichwörter der Autor:innen

A1A2AA2BA3adenosineadenosine receptorstherapeutic potential

Substanzen

Receptors, Purinergic P1LigandsPurinergic P1 Receptor Antagonists

Autor:innen und Institutionen

  • Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
  • Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, 44121 Ferrara, Italy.
  • University of Ferrara, 44121 Ferrara, Italy.

ORCID-Profile: Fabrizio Vincenzi, Silvia Pasquini, Chiara Contri, Stefania Merighi, Katia Varani

Förderung

  • Italian Ministry of University and Research (MUR)
  • Ministry of University and Research (MUR) National Recovery and Resilience Plan (NRRP)

Zitieren

APA

Vincenzi, F., Pasquini, S., Contri, C., Cappello, M., Nigro, M., Travagli, A., Merighi, S., Gessi, S., Borea, P. A., & Varani, K. (2023). Pharmacology of Adenosine Receptors: Recent Advancements. Biomolecules, 13(9), 1387. https://doi.org/10.3390/biom13091387

Vancouver

Vincenzi F, Pasquini S, Contri C, Cappello M, Nigro M, Travagli A, et al. Pharmacology of Adenosine Receptors: Recent Advancements. Biomolecules. 2023;13(9):1387. doi:10.3390/biom13091387

BibTeX
@article{Vincenzi2023,
  author = {Vincenzi, Fabrizio and Pasquini, Silvia and Contri, Chiara and Cappello, Martina and Nigro, Manuela and Travagli, Alessia and Merighi, Stefania and Gessi, Stefania and Borea, Pier Andrea and Varani, Katia},
  title = {Pharmacology of Adenosine Receptors: Recent Advancements},
  journal = {Biomolecules},
  year = {2023},
  volume = {13},
  number = {9},
  pages = {1387},
  doi = {10.3390/biom13091387}
}
Kostenlos starten →